Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KB | Q9UBF8 | 1/20 | 1.00 |
| ▸ | MAPK14 | Q16539 | 19/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinviroxime SCHEMBL149064 | 1.00 | PI4KB (1.00) | PI4KBMAPK14CYP3A4 | |
| Viroxime SCHEMBL29365398 | 1.00 | PI4KB (1.00) | PI4KBMAPK14CYP3A4 | |
| Viroxime SCHEMBL3586 | 1.00 | PI4KB (1.00) | PI4KBMAPK14CYP3A4 | |
| Enviroxime SCHEMBL6475190 | 0.86 | PI4KB (0.74) | PI4KBMAPK14CYP3A4 | |
| SCHEMBL10906292 | 0.85 | PI4KB (0.74) | PI4KBMAPK14CYP3A4 | |
| SCHEMBL4837467 | 0.85 | PI4KB (0.74) | PI4KBMAPK14CYP3A4 | |
| SCHEMBL11073939 | 0.84 | PI4KB (0.72) | PI4KBMAPK14CYP3A4 | |
| SCHEMBL11149101 | 0.83 | PI4KB (0.71) | PI4KBMAPK14CYP3A4 | |
| Enviradene SCHEMBL10429409 | 0.83 | PI4KB (0.71) | PI4KBMAPK14CYP3A4 | |
| Enviradene SCHEMBL29367493 | 0.83 | PI4KB (0.71) | PI4KBMAPK14CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2027 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026043843-A1 | TETRAHYDROPYRIMIDINE (THP) IONIZABLE LIPIDS FOR EFFICIENT MRNA DELIVERY | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) | 2026-02-26 | — | — | WO | claimed |
| WO-2024215771-A1 | SUBSTITUTED PHENYL ETHYNYL PYRIMIDINES AS POTENT INHIBITORS OF ALPHAVIRUSES | SOUTHERN RESEARCH INSTITUTE (US) | 2024-10-17 | — | — | WO | claimed |
| EP-4262812-A1 | 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS | Southern Research Institute (US) | 2023-10-25 | — | — | EP | claimed |
| WO-2023122212-A2 | SUBSTITUTED PHENYL ETHYNYL PYRIDINE CARBOXAMIDES AS POTENT INHIBITORS OF SARS VIRUS | SOUTHERN RESEARCH INSTITUTE (US) | 2023-06-29 | — | — | WO | claimed |
| EP-4125845-A1 | NOVEL 2-PYRIMIDONE ANALOGS AS POTENT ANTIVIRAL AGENTS AGAINST ALPHAVIRUSES | Southern Research Institute (US) | 2023-02-08 | — | — | EP | claimed |
| EP-4021413-A1 | LIPOSOMAL TROPONOID COMPOUND FORMULATIONS | United States Government as Represented by The Department of Veterans Affairs (US) | 2022-07-06 | — | — | EP | claimed |
| WO-2022133323-A1 | 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS | SOUTHERN RESEARCH INSTITUTE (US) | 2022-06-23 | — | — | WO | claimed |
| CN-114432305-A | Application of CAY10603 in preparing medicine for preventing and treating coronavirus | 中国科学院深圳先进技术研究院 | 2022-05-06 | — | — | CN | claimed |
| CN-114432287-A | Application of ITF2357 in preparation of medicine for preventing and treating coronavirus | 中国科学院深圳先进技术研究院 | 2022-05-06 | — | — | CN | claimed |
| CN-114432303-A | Application of panobinostat in preparation of medicine for preventing and treating coronavirus | 中国科学院深圳先进技术研究院 | 2022-05-06 | — | — | CN | claimed |
| US-4956351-A | INCLUSION COMPLEXESOFVIRICIDES; RHINITIS; SUSTAINED RELEASE; NONIRRITATING TO MUCOUS MEMBRANE | JANSSEN PHARMACEUTICA N.V. FRAME-543 (BE) | 1990-09-11 | — | — | US | claimed |
| WO-1990006775-A1 | A NOVEL NONPHOSPHOLIPID LIPOSOME COMPOSITION FOR SUSTAINED RELEASE OF DRUGS | LIPOSOME TECHNOLOGY, INC. (US) | 1990-06-28 | — | — | WO | claimed |
| EP-0207116-A1 | IMPROVEMENTS RELATING TO THE TREATMENT CONTROL AND PREVENTION OF RHINOVIRUS INFECTIONS | TYRRELL, David Arthur John (GB) | 1987-01-07 | — | — | EP | claimed |
| WO-1986003412-A1 | IMPROVEMENTS RELATING TO THE TREATMENT CONTROL AND PREVENTION OF RHINOVIRUS INFECTIONS | TYRRELL DAVID ARTHUR JOHN | 1986-06-19 | — | — | WO | claimed |
| EP-0047122-A2 | Intranasal formulation | ELI LILLY AND COMPANY (US) | 1982-03-10 | — | — | EP | claimed |
| US-4309258-A | Conversion of benzimidazole isomers | ELI LILLY AND COMPANY (US) | 1982-01-05 | — | — | US | claimed |
| US-4289782-A | PARTICULARLY FOR INHIBITING GROWTH OF RHINOVIRUSES | ELI LILLY AND COMPANY (US) | 1981-09-15 | — | — | US | claimed |
| EP-0015339-A1 | Separation of syn and anti 1-alkylsulfonyl-2-amino-5(6)hydroximinomethylbenzimidazole derivatives | ELI LILLY AND COMPANY (US) | 1980-09-17 | — | — | EP | claimed |
| US-4191832-A | Separation of syn and anti oximes of 1-sulfonyl-2-aminobenzimidazoles | ELI LILLY AND COMPANY (US) | 1980-03-04 | — | — | US | claimed |
| US-4118742-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1978-10-03 | — | — | US | claimed |